FDA Import Refusal SCS-1426130-0/11/1 — Glaxosmithkline Consumer Healthcare
The FDA refused shipment SCS-1426130-0/11/1 from Glaxosmithkline Consumer Healthcare (Australia) on Oct 19, 2018. The refused product falls under Drugs and Biologics — XYLOMETAZOLINE HCL (ADRENERGIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Oct 19, 2018
- Country
- Australia
- Product Category
- Drugs and Biologics
- Product Code
- 60CAY53 XYLOMETAZOLINE HCL (ADRENERGIC)
- Charges
- 75